{"schema_version":"alpha-profile-public-v1","slug":"robert-azelby","canonical_url":"https://registry.alpha.ac/people/robert-azelby","as_of":"2026-09-22T12:58:35.187175+00:00","published_at":"2026-09-02T02:37:20.627338+00:00","last_reviewed_at":"2026-05-15T20:34:39.815+00:00","identity":{"display_name":"Robert Azelby","headshot_url":null,"headshot_media":null,"profile_kind":"director","role_tags":["director"],"current_role":{"company_name":"Terns Pharmaceuticals","company_slug":null,"exchange":"NASDAQ","ticker":"TERN","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2025-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1831363/000095017025060138/tern-def14a-2025.htm","effective_date":"2025-04-29","last_checked_at":"2026-05-10T00:22:55.238+00:00"}},"photo_match":null},"assurance":{"is_claimed":false,"status":"unverified","assurance_level":null,"method":null,"verified_at":null,"expires_at":null},"claiming":{"eligible":true,"label":"Is this you? Claim your Alpha Profile","claim_url":"https://terminal.alpha.ac/claim-profile?person=robert-azelby","suggest_edit_label":"Suggest an edit","suggest_edit_url":"https://terminal.alpha.ac/claim-profile?person=robert-azelby&mode=suggest","canonical_record_will_be_reused":true,"canonical_facts_owner_controlled":false},"presentation":{"schema_version":"alpha-profile-presentation-v1","state":"alpha_editorial","version":0,"published_at":null,"headline":null,"headline_evidence":null,"location":null,"photo":null,"cover":null,"about":["Robert Azelby served as President and Chief Executive Officer of Eliem Therapeutics from October 2020 to February 2023 and as Chief Executive Officer of Alder BioPharmaceuticals from June 2018 until its acquisition by H. Lundbeck in 2019. He has extensive experience in the biotech and biopharma space with roles at Juno Therapeutics and Amgen."],"links":[],"sources":[],"featured":[],"competencies":[],"board_preferences":null,"board_service":[{"organization":"Terns Pharmaceuticals","title":"Director","period":"2025-01-01 · current","evidenceLabel":"sec_proxy","evidenceState":"verified","sourceUrl":"https://www.sec.gov/Archives/edgar/data/1831363/000095017025060138/tern-def14a-2025.htm"},{"organization":"ADC Therapeutics SA","organizationId":"adc-therapeutics-sa","title":"Director","period":"2023-01-01 · current","evidenceLabel":"sec_proxy","evidenceState":"verified","sourceUrl":"https://www.sec.gov/Archives/edgar/data/1771910/000114036126015491/ny20070055x2_def14a.htm"}],"experience":[],"education":[],"credentials":[],"section_order":null,"hidden_sections":[],"limitations":["Presentation fields do not alter independently verified Alpha Profile facts.","Owner-supplied résumé records retain their field-level evidence state.","Only confirmed company_person_roles with public evidence. Website governed_site_fallback rows are not invented. about/links are stored people.profile_summary/bio and linkedin_url only. Dates stay undisclosed when the role has no start_date. SoFi Bank is not SoFi Technologies."]},"presentation_authority":"confirmed_company_person_roles","roles":[{"company_name":"Terns Pharmaceuticals","company_slug":null,"exchange":"NASDAQ","ticker":"TERN","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2025-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1831363/000095017025060138/tern-def14a-2025.htm","effective_date":"2025-04-29","last_checked_at":"2026-05-10T00:22:55.238+00:00"}},{"company_name":"ADC Therapeutics SA","company_slug":"adc-therapeutics-sa","exchange":"NYSE","ticker":"ADCT","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2023-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1771910/000114036126015491/ny20070055x2_def14a.htm","effective_date":"2026-04-20","last_checked_at":"2026-04-24T15:46:02.182+00:00"}}],"claims":[{"claim_type":"ai_ml_experience","claim_value":false,"claim_text":"Proxy extraction classified AI/ML experience for Robert Azelby as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T20:34:39.970516+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ADCT DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1771910/000114036126015491/ny20070055x2_def14a.htm","published_at":"2026-04-20T00:00:00+00:00","last_checked_at":"2026-05-15T20:34:39.872884+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"board_role","claim_value":"Director","claim_text":"Robert Azelby currently serves as Director at ADC Therapeutics SA.","claim_state":"verified","valid_from":"2026-04-20","valid_to":null,"confidence":0.92,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T20:34:39.937346+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ADCT DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1771910/000114036126015491/ny20070055x2_def14a.htm","published_at":"2026-04-20T00:00:00+00:00","last_checked_at":"2026-05-15T20:34:39.872884+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"board_role","claim_value":"Director","claim_text":"Robert Azelby currently serves as Director at Terns Pharmaceuticals.","claim_state":"verified","valid_from":"2025-04-29","valid_to":null,"confidence":0.92,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-11T06:23:08.92691+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"TERN DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1831363/000095017025060138/tern-def14a-2025.htm","published_at":"2025-04-29T00:00:00+00:00","last_checked_at":"2026-05-11T06:23:08.843627+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"committee_assignments","claim_value":["Audit","Compensation"],"claim_text":"Robert Azelby serves on Audit, Compensation.","claim_state":"verified","valid_from":"2026-04-20","valid_to":null,"confidence":0.88,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T20:34:39.954825+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ADCT DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1771910/000114036126015491/ny20070055x2_def14a.htm","published_at":"2026-04-20T00:00:00+00:00","last_checked_at":"2026-05-15T20:34:39.872884+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"committee_assignments","claim_value":["Compensation"],"claim_text":"Robert Azelby serves on Compensation.","claim_state":"verified","valid_from":"2025-04-29","valid_to":null,"confidence":0.88,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-11T06:23:08.949707+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"TERN DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1831363/000095017025060138/tern-def14a-2025.htm","published_at":"2025-04-29T00:00:00+00:00","last_checked_at":"2026-05-11T06:23:08.843627+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"cybersecurity_experience","claim_value":false,"claim_text":"Proxy extraction classified cybersecurity experience for Robert Azelby as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T20:34:40.006283+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ADCT DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1771910/000114036126015491/ny20070055x2_def14a.htm","published_at":"2026-04-20T00:00:00+00:00","last_checked_at":"2026-05-15T20:34:39.872884+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"technology_background","claim_value":false,"claim_text":"Proxy extraction classified technology background for Robert Azelby as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-15T20:34:39.988742+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"ADCT DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1771910/000114036126015491/ny20070055x2_def14a.htm","published_at":"2026-04-20T00:00:00+00:00","last_checked_at":"2026-05-15T20:34:39.872884+00:00","relation":"supports","excerpt_locator":null}]},{"subject":"alpha:person:robert-azelby","claim_type":"board_service","claim_value":{"tags":[],"title":"Director","period":"2025-01-01 · current","organization":"Terns Pharmaceuticals","organization_id":null},"claim_text":"Director at Terns Pharmaceuticals (2025-01-01 · current)","valid_from":null,"valid_to":null,"verification_status":"confirmed","date_precision":"period_text_only","evidence":[{"source_url":"https://www.sec.gov/Archives/edgar/data/1831363/000095017025060138/tern-def14a-2025.htm","label":"sec_proxy","evidence_state":"verified"}],"claim_state":"confirmed","version":1},{"subject":"alpha:person:robert-azelby","claim_type":"board_service","claim_value":{"tags":[],"title":"Director","period":"2023-01-01 · current","organization":"ADC Therapeutics SA","organization_id":"adc-therapeutics-sa"},"claim_text":"Director at ADC Therapeutics SA (2023-01-01 · current)","valid_from":null,"valid_to":null,"verification_status":"confirmed","date_precision":"period_text_only","evidence":[{"source_url":"https://www.sec.gov/Archives/edgar/data/1771910/000114036126015491/ny20070055x2_def14a.htm","label":"sec_proxy","evidence_state":"verified"}],"claim_state":"confirmed","version":1}],"network":{"schema_version":"alpha-profile-network-public-v1","relationships":[],"relationship_pathfinding":false,"authentication_prompt":"Sign in to see how you're connected.","limitations":["Representative factual associations only.","Shared contexts do not assert personal acquaintance.","Anonymous graph traversal is not available."]},"permissions":{"classification":"open_public_projection","public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false},"limitations":["Only permissioned public claims and evidence are included.","Absence of a claim is not evidence that the underlying fact is false.","Public retrieval does not grant model-training or redistribution rights.","Private relationships and Council activity are excluded."],"structured_data":{"@context":"https://schema.org","@type":"ProfilePage","@id":"https://registry.alpha.ac/people/robert-azelby#profile","url":"https://registry.alpha.ac/people/robert-azelby","dateModified":"2026-05-15T20:34:39.815+00:00","mainEntity":{"@type":"Person","@id":"https://registry.alpha.ac/people/robert-azelby#person","name":"Robert Azelby","url":"https://registry.alpha.ac/people/robert-azelby","jobTitle":"Director","worksFor":{"@type":"Organization","name":"Terns Pharmaceuticals","tickerSymbol":"NASDAQ: TERN"},"affiliation":[{"@type":"OrganizationRole","roleName":"Director","startDate":"2025-01-01","memberOf":{"@type":"Organization","name":"Terns Pharmaceuticals","tickerSymbol":"NASDAQ: TERN"}},{"@type":"OrganizationRole","roleName":"Director","startDate":"2023-01-01","memberOf":{"@type":"Organization","name":"ADC Therapeutics SA","url":"https://registry.alpha.ac/companies/adc-therapeutics-sa","tickerSymbol":"NYSE: ADCT"}}]},"isBasedOn":[{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1771910/000114036126015491/ny20070055x2_def14a.htm","name":"ADCT DEF 14A director slate"},{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1831363/000095017025060138/tern-def14a-2025.htm","name":"TERN DEF 14A director slate"}],"mainEntityOfPage":"https://registry.alpha.ac/people/robert-azelby"},"trust":{"schema_version":"alpha-profile-trust-v1","verification":{"schema_version":"alpha-verification-states-v1","state":"corroborated","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":9,"corroborated":1,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"At least one published claim is corroborated by two or more public sources. Profile ownership is unclaimed."},"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":10,"under_review_claim_count":0,"owner_supplied_claim_count":0,"evidence_record_count":6,"distinct_source_count":2,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"corroborated","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":9,"corroborated":1,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"At least one published claim is corroborated by two or more public sources. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":10,"corroborated_claims":1,"sources":6,"distinct_sources":2,"role_claims":2,"last_reviewed_at":"2026-05-15T20:34:39.815+00:00","observed_at":"2026-09-22T12:58:35.187175+00:00","freshness_days":130}},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"}},"projection":{"schema_version":"alpha-profile-projection-v5","entity":{"kind":"person","slug":"robert-azelby","canonical_url":"https://registry.alpha.ac/people/robert-azelby"},"publication":{"published_at":"2026-09-02T02:37:20.627338+00:00","last_reviewed_at":"2026-05-15T20:34:39.815+00:00","as_of":"2026-09-22T12:58:35.187175+00:00"},"representations":{"html":{"href":"https://registry.alpha.ac/people/robert-azelby","media_type":"text/html"},"json":{"href":"https://registry.alpha.ac/api/public/profiles/robert-azelby","media_type":"application/json"},"markdown":{"href":"https://registry.alpha.ac/people/robert-azelby.md","media_type":"text/markdown"},"structured_data":{"embedded":true,"media_type":"application/ld+json"},"share_image":null},"permissions":{"public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false}}}